Sedana Medical secures data exclusivity and market protection for Sedaconda[®] (isoflurane) until 2031
Non-regulatory
Sedana Medical AB (publ) announces that the European Medicines Agency’s Paediatric Committee has issued a positive opinion regarding the compliance with the company’s Paediatric Investigation Plan. This confirms data exclusivity and market protection…